BIRC5 and malignant colon neoplasm: A reduced protein expression of the proliferation marker Ki-67 as well as reduced mRNA expression of survivin (a tumor progression marker) was observed in all colon cancer cell lines in vitro following treatment with MO compared to control non-treated cells.